Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.390
-0.160 (-10.32%)
Mar 31, 2025, 10:59 AM EDT - Market open

Cabaletta Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Selling, General & Admin
27.9419.2414.8413.8212.72
Upgrade
Research & Development
97.255.4239.332.4921.11
Upgrade
Operating Expenses
125.1474.6654.1446.3133.83
Upgrade
Operating Income
-125.14-74.66-54.14-46.31-33.83
Upgrade
Interest Expense
-0.75----
Upgrade
Interest & Investment Income
10.036.991.160.020.49
Upgrade
EBT Excluding Unusual Items
-115.86-67.68-52.98-46.29-33.34
Upgrade
Pretax Income
-115.86-67.68-52.98-46.29-33.34
Upgrade
Net Income
-115.86-67.68-52.98-46.29-33.34
Upgrade
Net Income to Common
-115.86-67.68-52.98-46.29-33.34
Upgrade
Shares Outstanding (Basic)
5041292623
Upgrade
Shares Outstanding (Diluted)
5041292623
Upgrade
Shares Change (YoY)
20.93%39.54%14.01%11.20%323.18%
Upgrade
EPS (Basic)
-2.34-1.65-1.81-1.80-1.44
Upgrade
EPS (Diluted)
-2.34-1.65-1.81-1.80-1.44
Upgrade
Free Cash Flow
--54.24-48.83-35.28-27.41
Upgrade
Free Cash Flow Per Share
--1.32-1.66-1.37-1.18
Upgrade
EBITDA
-123.48-73.23-52.96-45.58-33.48
Upgrade
D&A For EBITDA
1.661.431.180.730.35
Upgrade
EBIT
-125.14-74.66-54.14-46.31-33.83
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q